The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake

British Journal of Nutrition

Volumn 103, Issue 2, 2010, Pages 249-255

  Cao, Jie ^a   Zhang, Ying ^a   Chen, Wei ^a   Zhao, Xiujuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Diet; Flavones; Flavonols; Plasma concentrations

Indexed keywords

APIGENIN; BIOLOGICAL MARKER; FLAVONOID; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; QUERCETIN; 3-METHYLQUERCETIN; FLAVONOL DERIVATIVE; KAEMPFEROL DERIVATIVE; QUERCETIN 3 METHYL ETHER;

ADULT; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CELERY; DIET RESTRICTION; DIETARY INTAKE; FOOD ANALYSIS; FOOD COMPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; NORMAL HUMAN; PLANT LEAF; QUANTITATIVE ANALYSIS; BLOOD; BODY MASS; CALORIC INTAKE; MEDICAL RECORD; PATIENT SELECTION;

APIUM GRAVEOLENS VAR. DULCE;

ADULT; APIGENIN; BIOLOGICAL MARKERS; BODY MASS INDEX; DIET RECORDS; ENERGY INTAKE; FASTING; FLAVONOIDS; FLAVONOLS; FOOD ANALYSIS; HUMANS; KAEMPFEROLS; LUTEOLIN; PATIENT SELECTION; QUERCETIN; YOUNG ADULT;

EID: 75549086308     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450999170X     Document Type: Article

References (39)

1. Lwashina T (2000) The structure and distribution of the flavonoids in plants. J plant res 113, 287-299.
2. Middleton EJ, Kandaswami C & Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673-751.
3. Arts ICW & Hollman PCH (2005) Polyphenols and disease risk in epidemiological studies. Am J Clin Nutr 81, Suppl. 1, 317S-325S.
4. Geleijnse JM, Launer LJ, Van der Kuip DA, et al. (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: The Rotterdam Study. Am J Clin Nutr 75, 880-886.
5. Erdman JW Jr, Carson L, Kwik-Uribe C, et al. (2008) Effects of cocoa flavanols on risk factors for cardiovascular disease. Asia Pac J Clin Nutr 17, Suppl. 1, 284-287.
6. Knekt P, Isotupa S, Rissanen H, et al. (2000) Quercetin intake and the incidence of cerebrovascular disease. Eur J Clin Nutr 54, 415-417.
7. Sesso HD, Gaziano JM, Liu S, et al. (2003) Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 77, 1400-1408.
8. He S, Sun C & Pan Y (2008) Red wine polyphenols for cancer prevention. Int J Mol Sci 9, 842-853.
9. Goldbohm RA, Hertog MGL, Brants HAM, et al. (1998) Intake of flavonoids and cancer risk: a prospective cohort study. In Polyphenols in Food, pp. 159-166 [R Armado, H Andersson, S Bardócz and F Serra, editors]. Luxembourg: Office for Official Publications of the European Communities.
10. Beecher GR (2003) Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133, 3048S-3054S.
11. Crews H, Alink G, Andersen R, et al. (2001) A critical assessment of some biomarker approaches linked with dietary intake. Br J Nutr 86, Suppl. 1, S5-S35.
12. Erlund I, Meririnne E, Alfthan G, et al. (2001) Plasma kinetics and urinary excretion of the flavanones naringenin and hes-peretin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131, 235-241.
13. Ito H, Gonthier MP, Manach C, et al. (2005) Polyphenol levels in human urine after intake of six different polyphenol-rich beverages. Br J Nutr 94, 500-509.
14. Erlund I, Kosonen T, Alfthan G, et al. (2000) Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 56, 545-553.
15. Cao J, Zhao XJ, Wu K, et al. (2008) Simultaneous determination of five flavonoid compounds in vegetables and fruits by high performance liquid chromatography. Chinese J Prev Med Inf 7, 525-527.
16. Zhao XJ, Wu K, Zhao Y, et al. (2007) High performance liquid chromatographic method for the determination of apigenin and selected flavonoids in human plasma using electrochemical detection. Chinese J Anal Chem 10, 1517-1520.
17. Nielsen SE, Breinholt V, Justesen U, et al. (1998) In vitro biotrabsformation of flavonoids by rat liver microsomes. Xenobiotica 28, 389-401.
18. Linseisen J, Radtke J & Wolfram G (1997) Flavonoid intake of adults in a Bavarian subgroup of the national food consumption survey. Z Ernahrungswiss 36, 403-412.
19. Radtke J, Linseisen J & Wolfram G (2002) Fasting plasma concentrations of selected flavonoids as markers of their ordinary dietary intake. Eur J Nutr 41, 203-209.
20. Scalbert A & Williamson G (2000) Dietary intake and bioavail-ability of polyphenols. J Nutr 130, Suppl. 8S, 2073S-2085S.
21. Kinoshita T, Lepp Z & Chuman H (2005) Construction of a novel database for flavonoids. J Med Invest 52, 291-292.
22. Peterson J & Dwyer J (2000) An informatics approach to flavo-noid database development. J Food Compos Anal 13, 441-454.
23. Graefe EU, Wittig J, Mueller S, et al. (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41, 492-499.
24. Hollman PC, van Trijp JM, Buysman MN, et al. (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418, 152-156.
25. Manach C, Morand C, Crespy V, et al. (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426, 331-336.
26. Xu X, Wang HJ, Murphy PA, et al. (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825-832.
27. King RA & Bursill DB (1998) Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 67, 867-872.
28. Shelnutt SR, Cimino CO, Wiggins PA, et al. (2002) Pharmaco-kinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr 76, 588-594.
29. Ader P, Block M, Pietzsch S, et al. (2001) Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett 162, 175-180.
30. Hollman PC, Bijsman MN, van Gameren Y, et al. (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 31, 569-573.
31. Erlund I, Meririnne E, Alfthan G, et al. (2001) Plasma kinetics and urinary excretion of the flavanones naringenin and hespere-tin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131, 235-241.
32. Manach C, Morand C, Crespy V, et al. (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426, 331-336.
33. Kumpulainen JT, Lehtonen M & Mattila P (1999) Trolox equivalent antioxidant capacity of average flavonoids intake in Finland. In Natural Antioxidants and Anticarcinogens in Nutrition, Proceedings of the Second International Conference on Natural Antioxidants, pp. 141-150 [JT Kumpulainen and JT Salonen, editors]. Cambridge: The Royal Society of Chemistry.
34. Zhu BT, Ezell EL & Liehr JG (1994) Catechol-O-methyltrans- ferasecatalyzed rapid O-methylation of mutagenic flavonoids. J Biol Chem 269, 292-299.
35. Nielsen SE, Kall M, Justesen U, et al. (1997) Human absorption and excretion of flavonoids after broccoli consumption. Cancer Lett 114, 173-174.
36. Noroozi M, Burns J, Crozier A, et al. (2000) Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr 54, 143-149.
37. Nielsen SE, Freese R, Kleemola P, et al. (2002) Flavonoids in human urine as biomarkers for intake of fruits and vegetables. Cancer Epidemiol Biomarkers Prev 11, 459-466.
38. Meyer H, Bolarinwa A, Wolfram G, et al. (2006) Bioavailability of apigenin from apiin-rich parsley in humans. Ann Nutr Metab 50, 167-172.
39. Zino S, Skeaff M, Williams S, et al. (1997) Randomised controlled trial of effect of fruit and vegetable consumption on plasma concentrations of lipids and antioxidants. Br Med J 314, 1787-1791.